[Controlled supply of tocilizumab during the COVID-19 pandemic and its influence on the treatment of rheumatological patients.]

Autor: Sara, Ortiz Pérez, José Manuel, Caro Teller, Carmen, García Muñoz, Paola, Herraiz Robles, Fernando, Lozano Morillo, José Luis, Pablos Álvarez, José Miguel, Ferrari Piquero

Publikováno v: Revista espanola de salud publica. 95

Intravenous (IV) tocilizumab has been used to stop the inflammatory phase of SARS-CoV-2 infection. To preserve the largest number of IV units for this use, the Spanish Agency for Medicines and Health Products (AEMPS) carried out a controlled supply o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::03a3d19ba943d9b71fda41e596c30cdf
https://pubmed.ncbi.nlm.nih.gov/34803159

Quality of the record of drug-related problems in a database for voluntary adverse event reporting

Autor: Maria Teresa, Aznar-Saliente, Laura, Roca-Aznar, Amparo, Talens-Bolós, Paola, Herraiz-Robles, Manuel, Bonete-Sánchez, Laia, Pons-Martínez, Borja, Marcos-Ribes

Publikováno v: Farmacia Hospitalaria v.41 n.4 2017
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Farmacia Hospitalaria, Vol 41, Iss 4, Pp 508-517 (2017)

To determine the number and type of errors found in the record of drug-related problems in the SINEA database, an electronic system for voluntary reporting of adverse events in healthcare, in order to quantify the differences between the raw and refi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::daf852c83df8889f63d142c87f0665f7
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000400508